𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The ontogeny of B lymphocytes IV. Induction signals mediating phenotypic conversion of PC.1− to PC.1+B cells

✍ Scribed by U. Hämmerling; Ann F. Chin


Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
580 KB
Volume
7
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The present study presents evidence that spleen and lymph node cell populations contain a distinct subpopulation of B lymphocytes amounting to < 1 % of the total, which are committed and poised to the expression of the PC. 1 alloantigen, and which can be triggered in vitro to express PC.1. The pheno‐type of the PC.l‐inducible cells has been determined as Ig^+^ Ia^+^ complement receptor (CR)^+^ PC.l^−^ which characteristically is associated with mature lymphocytes. Since the PC.l alloantigen identifies plasmacytes, the induction experiments imply that the latter cells are in principle descendents of CR^+^ B lymphocytes.

The induction signal mediating PC.l^−^ to PC.1^+^ conversion is different from that mediating early pro‐B cell induction. Inducing agents of PC.l^−^←PC.1 ^+^ include carbamylcholine, thymopoietin, prostaglandin F~2α~ and 8‐bromo cyclic GMP, all of which have previously been shown to inhibit early pro‐B cell induction. Conversely, most agents inducing phenotype conversion in early pro‐B cells (e.g. lipopolysaccharide, tumor‐necrotizing serum, isoproterenol, prostaglandin E^1^ and dibutyryl cyclic AMP) are strong inhibitors of PC. 1 induction. The results suggest that inducible B lymphocytes are under dual control of agents imparting opposing signals to them, but that the mode in which they respond is reversed when they have matured to the CR^+^ state. Since PC. 1 expression coincides largely with differentiation to antibody‐forming cells, the reversal of responses to regulatory signals may be of significance as a safeguard against spurious activation of B lymphocytes.


📜 SIMILAR VOLUMES


High expression of Bfl-1 contributes to
✍ Alejo A. Morales; Anna Olsson; Fredrik Celsing; Anders Österborg; Mikael Jondal; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB 👁 1 views

## Abstract In order to identify regulatory genes involved in the development of an apoptosis‐resistant phenotype in patients with chemotherapy refractory B‐cell chronic lymphocytic leukemia (B‐CLL) expression of apoptosis‐regulating genes in B‐CLL cells was quantified using cDNA arrays and RT‐PCR.